A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: Association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome

Acta Diabetologica

Volumn 40, Issue 4, 2003, Pages 163-172

  Nauck, M A ^a,b,c   Meier, J J ^c   Wolfersdorff, A V ^b   Tillil, H ^d   Creutzfeldt, W ^b   Kobberling J ^b,d  

^a Diabetes Center Bad Lauterberg   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c ST JOSEF HOSPITAL   (Germany)

^d HELIOS KLINIKUM WUPPERTAL   (Germany)

Author keywords

Dyslipidemia; HDL cholesterol; Hyperinsulinemia; Hypertension; Insulin resistance; LDL cholesterol; Metabolic syndrome; Obesity; Oral glucose tolerance; Triglycerides; Type 2 diabetes

Indexed keywords

C PEPTIDE; CHOLESTEROL; FATTY ACID; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FATTY ACID BLOOD LEVEL; FEMALE; FOLLOW UP; GERMANY; HIP; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; KRUSKAL WALLIS TEST; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARAMETER; POPULATION; PRIORITY JOURNAL; RELATIVE; RISK; TRIACYLGLYCEROL BLOOD LEVEL; WORLD HEALTH ORGANIZATION;

AGED; BLOOD GLUCOSE; BODY CONSTITUTION; BODY MASS INDEX; C-PEPTIDE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FAMILY; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0346734379     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00592-003-0106-y     Document Type: Article

References (56)

1. Köbberling J, Tattersall R (1982) The genetics of diabetes mellitus. Academic, London
2. Köbberling J, Tillil H, Lorenz HJ (1985) Genetics of type 2a-and type 2b-diabetes mellitus. Diabetes Res Clin Pract 1[Suppl 1]:311 (abstract)
3. Tillil H, Köbberling J (1987) Age-corrected empirical risk estimates for first-degree relatives of NIDDM patients. Diabetes 36:93-97
4. Turner RC, Hattersley AT, Shawn JTE, Levy JC (1995) Type 2 diabetes: clinical aspects of molecular biological studies. Diabetes 44:1-10
5. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B et al (1996) A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 13:161-166
6. Gottlieb MS, Root HS (1968) Diabetes mellitus in twins. Diabetes 17:693-704
7. Barnett A, Eff C, Leslie R, Pyke D (1981) Diabetes in identical twins. Diabetologia 20:87-93
8. Köbberling J, Tattersall R (1982) Empirical risk figures for first degree relatives of non-insulin dependent diabetics. In: Köbberling J, Tillil H (eds) The genetics of diabetes mellitus. vol. 47. Academic, London, pp 201-209
9. DeFronzo RA, Ferranini E (1991) Insulin resistance. A multifaced syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194
10. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595-1607
11. Reaven GM, Hollenbeck CB, Chen YDI (1989) Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32:52-55
12. Reaven GM (1991) Insulin resistance, hyperinsulinaemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med 90[Suppl 2A]:7S-12S
13. Ferrannini E, Haffner SM, Mitchel BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 14:416-422
14. Reaven GM (1992) The role of insulin resistance and hyperinsulinemia in coronary heart disease. Metabolism 41 [Suppl 1]:16-19
15. Ferrannini E, Buzzigoli G, Bonadonna R et al (1987) Insulin resistance in essential hypertension. N Engl J Med 317:350-357
16. Bonadonna RC, Groop L, Kraemer N et al (1990) Obesity and insulin resistance in humans: a dose-response study. Metabolism 39:452-459
17. Axelrod L (1991) Insulin, prostaglandines, and the pathogenesis of hypertension. Diabetes 40:1223-1227
18. Haffner SM, Valdez RA, Hazuda HP et al (1992) Prospective analysis of the insulin-resistance syndrome (syndrome x). Diabetes 41:715-722
19. Krekora K, De Lucia D, Capani F, Donati MB, Iacoviello L (1996) Associatrion of coagulation factor V Arg506Gln mutation with non-insulin-dependent diabetes mellitus. Lancet 348:1666-1667
20. Mansfield MW, Heywood DM, Grant PJ (1996) Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM. Circulation 94:2171-2176
21. 2+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production. Diabteologia 42:167-176
22. Erpenstein A, Nauck M, Wirtz G et al (1993) A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2-diabetic patients. Diabetologia 36[Suppl 1]:277 (abstract)
23. Köbberling J (1970) Studies on the genetic heterogeneity of diabetes mellitus. Diabetologia 7:46-49
24. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502
25. WHO Study Group (1985) Diabetes mellitus. WHO Tech Rep Ser, n 727
26. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 21 [Suppl 1]:5-22
27. - (1992) Prevention of coronary heart disease: scientific background and new clinical guidlines. Nutr Metab Cardiovasc Dis 2:113-156
28. Hollenbeck NK, in Hollenbeck NkeHmat (1995) Summary of the Joint National Committee (JNC)-V and WHO/International Society of Hypertension (ISH) special reports. In: Braunwald E (ed) Atlas of heart diseases, vol 1. 13.1-13.16
29. Panzram G (1987) Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30:123-131
30. Gu L, Cowie CC, Harris MI (1998) Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 21:1138-1145
31. Vionet N, Hani E, Lesage S et al (1997) Genetics of NIDDM in France: studies with 19 candidate genes in affected sib pairs. Diabetes 46:1062-1068
32. Björntorp P (1991) Metabolic implications of body fat distribution. Diabetes Care 14:1132-1143
33. Pouliot MC, Després JP, Nadeau A et al (1992) Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41:826-834
34. Golay A, Zech L, Shi MZ et al (1987) High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using triated HDL. J Clin Endocrinol Metab 65:512-518
35. Ginsberg HN, Haffner SM, Mirchel BD, Stern MP (1991) Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Diabetes Care 14:839-855
36. Kaprhapää P, Malkki M, Laakso M (1994) Isolated low HDL cholesterol: an insulin-resistant state. Diabetes 43:411-417
37. Weidmann P, Ferrari P (1991) Central role of sodium in hypertension in diabetic subjects. Diabetes Care 14:220-232
38. Daly PA, Landsberg L (1991) Hypertension in obesity and NIDDM. Role of insulin and sympathetic nervous system. Diabetes Care 14:240-248
39. Lembo G, Napoli R, Capaldo B et al (1992) Abnormal sympathetic overactivity evoked by insulin in the sceletal muscle of patients with essential hypertension. J Clin Invest 90:24-29
40. Modan M, Haikin H, Almog S et al (1995) Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817
41. Donahue RP, Orchard TJ, Becker DJ, Kuller LH, Drash AL (1988) Physical activity, insulin sensitivity, and the lipoprotein profile in young adults: The Beaver County Study. Am J Epidemiol 127:95-103
42. Helmrich SP, Ragland DRL, Paffenbarger RS (1991) Physical activity and reduced occurence of non-insulin-dependent diabetes mellitus. N Engl J Med 325:147-152
43. Wannemathee SG, Shaper AG (1999) Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 22:1266-1272
44. Zavaroni I, Bonora E, Pagliara M et al (1989) Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702-706
45. Meigs JB, Mittleman MA, Nathan DM et al (2000) Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 283:221-228
46. Galvan AQ, Santoro D, Natali A et al (1992) Insulin sensitivity in familial hypercholesterolemia. Metabolism 42:1359-1364
47. Lindahl B, Weinehall L, Asplund K, Hallmans G (1999) Screening for impaired glucose tolerance: results from a population-based study in 21057 individuals. Diabetes Care 22:1988-1992
48. Abbasi F, McLaughlin T, Lamendola C et al (1999) Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers. J Clin Endocrinol Metab 84:3903-3906
49. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
50. Jarret RJ (1996) The cardiovascular risk associated with impaired glucose tolerance. Diabet Med 13:S15-S19
51. Bonora E, Kiechl S, Willeit J et al (1998) Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47:1643-1649
52. Harris MI (1996) Impaired glucose tolerance - prevalence and conversion to NIDDM. Diabet Med 13:S9-S11
53. Heine RJ, Nijpels G, Mooy JM (1996) New data on the rate of progression of impaired glucose tolerance to NIDDM and predicting factors. Diabet Med 13:S12-S14
54. Nijpels G (1998) Determinants for progression from inpaired glucose tolerance to non-insulin-dependent diabetes mellitus. Eur J Clin Invest 28:[Suppl 2]:8-13
55. Fontbonne A, Charles MA, Thilbult N et al (1991) Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population, the Paris Prospective Study, 15-year follow-up. Diabetologia 34:356-361
56. Matthews DR, Hosker JP, Rudenski AS, et al (1985) Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419